Logo image of CTOS

CUSTOM TRUCK ONE SOURCE INC (CTOS) Stock Fundamental Analysis

NYSE:CTOS - New York Stock Exchange, Inc. - US23204X1037 - Common Stock - Currency: USD

4.1  +0.19 (+4.86%)

After market: 4.1 0 (0%)

Fundamental Rating

2

Overall CTOS gets a fundamental rating of 2 out of 10. We evaluated CTOS against 49 industry peers in the Trading Companies & Distributors industry. CTOS has a bad profitability rating. Also its financial health evaluation is rather negative. CTOS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTOS had negative earnings in the past year.
In the past year CTOS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CTOS reported negative net income in multiple years.
CTOS had a positive operating cash flow in 4 of the past 5 years.
CTOS Yearly Net Income VS EBIT VS OCF VS FCFCTOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.82%, CTOS is doing worse than 81.63% of the companies in the same industry.
The Return On Equity of CTOS (-3.33%) is worse than 81.63% of its industry peers.
CTOS's Return On Invested Capital of 4.22% is on the low side compared to the rest of the industry. CTOS is outperformed by 69.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTOS is below the industry average of 8.96%.
Industry RankSector Rank
ROA -0.82%
ROE -3.33%
ROIC 4.22%
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
CTOS Yearly ROA, ROE, ROICCTOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

CTOS has a Operating Margin (6.70%) which is in line with its industry peers.
CTOS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 21.65%, CTOS is doing worse than 75.51% of the companies in the same industry.
CTOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.7%
PM (TTM) N/A
GM 21.65%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
CTOS Yearly Profit, Operating, Gross MarginsCTOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTOS is destroying value.
The number of shares outstanding for CTOS has been reduced compared to 1 year ago.
CTOS has more shares outstanding than it did 5 years ago.
CTOS has a better debt/assets ratio than last year.
CTOS Yearly Shares OutstandingCTOS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CTOS Yearly Total Debt VS Total AssetsCTOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that CTOS is in the distress zone and has some risk of bankruptcy.
CTOS has a Altman-Z score of 0.70. This is amonst the worse of the industry: CTOS underperforms 91.84% of its industry peers.
A Debt/Equity ratio of 1.76 is on the high side and indicates that CTOS has dependencies on debt financing.
CTOS's Debt to Equity ratio of 1.76 is on the low side compared to the rest of the industry. CTOS is outperformed by 77.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACC0.37
WACC11.48%
CTOS Yearly LT Debt VS Equity VS FCFCTOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CTOS has a Current Ratio of 1.30. This is a normal value and indicates that CTOS is financially healthy and should not expect problems in meeting its short term obligations.
CTOS has a Current ratio of 1.30. This is in the lower half of the industry: CTOS underperforms 77.55% of its industry peers.
A Quick Ratio of 0.25 indicates that CTOS may have some problems paying its short term obligations.
CTOS's Quick ratio of 0.25 is on the low side compared to the rest of the industry. CTOS is outperformed by 93.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.25
CTOS Yearly Current Assets VS Current LiabilitesCTOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

CTOS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -330.00%.
CTOS shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
The Revenue has been growing by 46.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-330%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%2.66%

3.2 Future

Based on estimates for the next years, CTOS will show a very strong growth in Earnings Per Share. The EPS will grow by 58.58% on average per year.
The Revenue is expected to grow by 6.52% on average over the next years.
EPS Next Y94.17%
EPS Next 2Y58.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.17%
Revenue Next 2Y6.86%
Revenue Next 3Y6.52%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTOS Yearly Revenue VS EstimatesCTOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CTOS Yearly EPS VS EstimatesCTOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTOS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 37.92 indicates a quite expensive valuation of CTOS.
69.39% of the companies in the same industry are cheaper than CTOS, based on the Price/Forward Earnings ratio.
CTOS is valuated expensively when we compare the Price/Forward Earnings ratio to 20.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 37.92
CTOS Price Earnings VS Forward Price EarningsCTOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTOS indicates a rather cheap valuation: CTOS is cheaper than 83.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.76
CTOS Per share dataCTOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTOS's earnings are expected to grow with 58.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.58%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTOS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUSTOM TRUCK ONE SOURCE INC

NYSE:CTOS (5/2/2025, 4:10:02 PM)

After market: 4.1 0 (0%)

4.1

+0.19 (+4.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners25.94%
Inst Owner Change0.21%
Ins Owners2.53%
Ins Owner Change12.15%
Market Cap928.57M
Analysts78.33
Price Target6.46 (57.56%)
Short Float %9.01%
Short Ratio6.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-96.61%
Min EPS beat(2)-142.24%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-266.75%
Min EPS beat(4)-553.59%
Max EPS beat(4)-50.98%
EPS beat(8)2
Avg EPS beat(8)-108.33%
EPS beat(12)5
Avg EPS beat(12)30.67%
EPS beat(16)6
Avg EPS beat(16)-145.16%
Revenue beat(2)0
Avg Revenue beat(2)-4.12%
Min Revenue beat(2)-6.04%
Max Revenue beat(2)-2.21%
Revenue beat(4)0
Avg Revenue beat(4)-7.36%
Min Revenue beat(4)-11.56%
Max Revenue beat(4)-2.21%
Revenue beat(8)4
Avg Revenue beat(8)1.2%
Revenue beat(12)6
Avg Revenue beat(12)0.76%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)2.7%
PT rev (3m)2.7%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-89.45%
EPS NY rev (1m)-60%
EPS NY rev (3m)-190.02%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)6.06%
Revenue NY rev (3m)6.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.92
P/S 0.52
P/FCF N/A
P/OCF 7.61
P/B 1.08
P/tB N/A
EV/EBITDA 6.76
EPS(TTM)-0.23
EYN/A
EPS(NY)0.11
Fwd EY2.64%
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)0.54
OCFY13.14%
SpS7.96
BVpS3.8
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -3.33%
ROCE 4.83%
ROIC 4.22%
ROICexc 4.22%
ROICexgc 6.85%
OM 6.7%
PM (TTM) N/A
GM 21.65%
FCFM N/A
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
ROICexc(3y)5.24%
ROICexc(5y)3.82%
ROICexgc(3y)9%
ROICexgc(5y)6.62%
ROCE(3y)5.98%
ROCE(5y)4.36%
ROICexcg growth 3Y112.25%
ROICexcg growth 5Y-5.47%
ROICexc growth 3Y121.67%
ROICexc growth 5Y-4.41%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 4.26
Cap/Depr 168.89%
Cap/Sales 22.1%
Interest Coverage 0.79
Cash Conversion 34.21%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.25
Altman-Z 0.7
F-Score4
WACC11.48%
ROIC/WACC0.37
Cap/Depr(3y)162.56%
Cap/Depr(5y)132.08%
Cap/Sales(3y)21.1%
Cap/Sales(5y)20.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-330%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y94.17%
EPS Next 2Y58.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%2.66%
Revenue Next Year8.17%
Revenue Next 2Y6.86%
Revenue Next 3Y6.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.78%
EBIT growth 3Y130.99%
EBIT growth 5Y22.21%
EBIT Next Year222.36%
EBIT Next 3Y55.51%
EBIT Next 5YN/A
FCF growth 1Y30.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y494.99%
OCF growth 3Y-4.24%
OCF growth 5Y45.35%